Topic

HKEX and the future of biotechi

At the heart of Asia’s largest biotech fundraising hub, HKEX fuels the global post-pandemic recovery story as an international capital market for biotech companies, connecting innovation, ideas and opportunities.

Paid Post:HKEX
Advertisement
  • HKEX’s listing reforms launched in 2018 opened a new pathway for pre-revenue biotech companies to raise funds, fuelling an era of growth
  • Hong Kong has become Asia’s largest biotech fundraising hub, and the second-largest globally
Paid Post:HKEX
Advertisement
Advertisement